DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Medroxyprogesterone (Medroxyprogesterone) - Dizziness - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dizziness (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Medroxyprogesterone where reactions include dizziness. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Medroxyprogesterone side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-27

Patient: female, weighing 65.8 kg (144.7 pounds)

Reactions: Migraine, Agitation, Drug Ineffective, Nausea, Disorientation, Stress, Gastric Disorder, Somnolence, Tremor, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness

Drug(s) suspected as cause:
Spiriva
    Indication: Asthma

Combivent
    Indication: Asthma

Trazodone Hydrochloride

Norvasc
    Indication: Hypertension

Advair HFA
    Indication: Asthma

Symbicort
    Indication: Bronchitis

Unspecified Nebulizer
    Indication: Bronchitis

Seroquel
    Indication: Bipolar I Disorder

Advair HFA
    Indication: Bronchitis

Symbicort
    Indication: Emphysema

Unspecified Nebulizer
    Indication: Emphysema

Inderal

Niaspan
    Dosage: 500 mg
    Indication: Blood Cholesterol Increased

Spiriva
    Indication: Emphysema

Seroquel
    Dosage: 100 mg
    Indication: Postpartum Stress Disorder
    Start date: 2006-01-01

Combivent
    Indication: Emphysema

Geodon

Aspirin
    Dosage: 81 mg

Lisinopril
    Dosage: 40 mg
    Indication: Hypertension

Unspecified Nebulizer
    Indication: Asthma

Unspecified Patch

Spiriva
    Indication: Bronchitis

Chantix

Medroxyprogesterone

Coreg
    Dosage: 25 mg

Advair HFA
    Indication: Emphysema

Symbicort
    Indication: Asthma

Combivent
    Indication: Bronchitis

Depakote

Estradiol

Chantix
    Dosage: 0.5 mg
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2012-02-01



Possible Medroxyprogesterone side effects in 50 year old female

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: 50 year old female, weighing 65.8 kg (144.8 pounds)

Reactions: Agitation, Migraine, Nausea, Disorientation, Somnolence, Stress, Gastric Disorder, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness

Drug(s) suspected as cause:
Estradiol

Spiriva
    Indication: Asthma

Advair Diskus 100 / 50
    Indication: Asthma

Unspecified Nebulizer
    Indication: Emphysema

Symbicort
    Dosage: unknown frequency
    Indication: Bronchitis

Symbicort
    Dosage: unknown frequency
    Indication: Emphysema

Spiriva
    Indication: Bronchitis

Unspecified Nebulizer
    Indication: Asthma

Unspecified Patch

Norvasc
    Indication: Hypertension

Advair Diskus 100 / 50
    Indication: Bronchitis

Unspecified Nebulizer
    Indication: Bronchitis

Chantix
    Indication: Emphysema

Seroquel
    Administration route: Oral
    Indication: Bipolar I Disorder
    Start date: 2006-01-01

Trazodone HCL

Combivent

Symbicort
    Dosage: unknown frequency
    Indication: Asthma

Lisinopril
    Administration route: Oral
    Indication: Hypertension

Depakote

Niaspan
    Indication: Hypercholesterolaemia

Spiriva
    Indication: Emphysema

Seroquel
    Administration route: Oral
    Indication: Postpartum Stress Disorder
    Start date: 2006-01-01

Aspirin

Coreg

Medroxyprogesterone

Inderal

Geodon

Advair Diskus 100 / 50
    Indication: Emphysema

Chantix
    Indication: Asthma

Chantix
    Indication: Bronchitis



Possible Medroxyprogesterone side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-06

Patient: female, weighing 65.8 kg (144.7 pounds)

Reactions: Agitation, Migraine, Nausea, Drug Ineffective, Disorientation, Gastric Disorder, Stress, Somnolence, Tremor, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness

Drug(s) suspected as cause:
Geodon

Trazodone Hydrochloride

Symbicort
    Indication: Asthma

Divalproex Sodium

Chantix
    Dosage: 0.5 mg
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2012-02-01

Norvasc
    Indication: Hypertension

Niaspan
    Dosage: 500 mg
    Indication: Blood Cholesterol Increased

Advair HFA
    Indication: Bronchitis

Unspecified Nebulizer
    Indication: Emphysema

Spiriva
    Indication: Bronchitis

Combivent
    Indication: Asthma

Coreg
    Dosage: 25 mg

Combivent
    Indication: Bronchitis

Aspirin
    Dosage: 81 mg

Advair HFA
    Indication: Asthma

Spiriva
    Indication: Asthma

Spiriva
    Indication: Emphysema

Lisinopril
    Dosage: 40 mg
    Indication: Hypertension

Medroxyprogesterone

Seroquel
    Dosage: 100 mg
    Indication: Postpartum Stress Disorder
    Start date: 2006-01-01

Symbicort
    Indication: Emphysema

Combivent
    Indication: Emphysema

Chantix

Inderal

Seroquel
    Indication: Bipolar I Disorder

Advair HFA
    Indication: Emphysema

Symbicort
    Indication: Bronchitis

Unspecified Nebulizer
    Indication: Bronchitis

Estradiol

Unspecified Nebulizer
    Indication: Asthma

Unspecified Patch



Possible Medroxyprogesterone side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-27

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Agitation, Migraine, Nausea, Drug Ineffective, Disorientation, Gastric Disorder, Somnolence, Stress, Tremor, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness

Drug(s) suspected as cause:
Inderal
    Dosage: unk

Lisinopril
    Dosage: 40 mg, daily
    Indication: Hypertension

Medroxyprogesterone
    Dosage: 2.5 mg, unk

Coreg
    Dosage: 12.5 mg, 2x/day

Spiriva
    Indication: Emphysema

Estradiol
    Dosage: 0.5 mg, unk

Advair Diskus 100 / 50
    Indication: Emphysema

Advair Diskus 100 / 50
    Dosage: unk
    Indication: Asthma

Advair Diskus 100 / 50
    Indication: Bronchitis

Symbicort
    Indication: Bronchitis

Norvasc
    Dosage: 10 mg, unk
    Indication: Hypertension

Acetylsalicylic Acid SRT
    Dosage: 81 mg, daily

Seroquel
    Dosage: 100 mg, daily
    Indication: Postpartum Disorder
    Start date: 2006-01-01

Chantix
    Dosage: 0.5 mg daily
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2012-02-01

Chantix
    Dosage: unk
    Administration route: Oral

Geodon
    Dosage: unk

Spiriva
    Indication: Bronchitis

Trazodone HCL
    Dosage: unk

Combivent
    Indication: Emphysema

Spiriva
    Dosage: unk
    Indication: Asthma

Seroquel
    Indication: Bipolar I Disorder

Niaspan
    Dosage: 500 mg, daily
    Indication: Blood Cholesterol Increased

Combivent
    Indication: Bronchitis

Depakote
    Dosage: unk

Symbicort
    Dosage: unk
    Indication: Asthma

Symbicort
    Indication: Emphysema

Combivent
    Dosage: unk
    Indication: Asthma



Possible Medroxyprogesterone side effects in female

Reported by a physician from United States on 2011-12-01

Patient: female, weighing 68.0 kg (149.6 pounds)

Reactions: Foot Deformity, Abdominal Pain, Endometrial Hyperplasia, Aortic Stenosis, Chronic Obstructive Pulmonary Disease, Vitamin B12 Deficiency, Dyspepsia, Uterine Leiomyoma, Breast Hyperplasia, Metabolic Disorder, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Ovarian Cyst, Coronary Artery Disease, Breast Mass, Cervical Dysplasia, Insomnia, Pelvic Pain, Fibrocystic Breast Disease, Fatigue, Chest Pain, Liver Function Test Abnormal, Dizziness, Depression, Gastrooesophageal Reflux Disease, Dyspnoea, Nausea, Amnesia, Rectocele, Dysuria, Visual Impairment

Drug(s) suspected as cause:
Premarin
    Dosage: 0.625 mg, unk
    Indication: Menopause
    Start date: 1990-11-26
    End date: 2000-11-01

Provera
    Dosage: 10 mg, unk
    Start date: 1990-11-26

Medroxyprogesterone
    Indication: Menopause
    Start date: 1991-01-01

Provera
    Dosage: 2.5 mg, unk
    End date: 2000-11-01

Ogen

Provera
    Indication: Menopause
    Start date: 1988-01-01
    End date: 1991-01-01

Premarin
    Start date: 1988-01-01
    End date: 1991-01-01

Prempro

Provera
    Start date: 1991-01-01

Premarin
    Administration route: Topical
    Indication: Menopause
    Start date: 1992-03-11
    End date: 1997-11-23

Hormones
    Administration route: Topical
    Indication: Menopause
    Start date: 1991-01-01

Climara

Estraderm
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1993-03-11

Estraderm
    Dosage: 0.05 mg, biw
    Start date: 1992-03-11
    End date: 1993-03-11

Cycrin
    Dosage: 2.5 mg, unk
    Indication: Menopause
    Start date: 1997-11-17
    End date: 1997-12-17

Other drugs received by patient: Calcium Carbonate; Fosamax; Plavix; Prednisone TAB; Tamoxifen Citrate; Zantac; Magnesium Sulfate; Tricor; Methotrexate; Fluconazole; Paxil; Naproxen (Aleve); Aspirin; Prevacid; Macrodantin; Folic Acid; Zoloft



Possible Medroxyprogesterone side effects in female

Reported by a lawyer from United States on 2011-11-29

Patient: female, weighing 68.0 kg (149.6 pounds)

Reactions: Abdominal Pain, Aortic Stenosis, Pelvic Pain, Chronic Obstructive Pulmonary Disease, Fatigue, Fibrocystic Breast Disease, Dyspepsia, Uterine Leiomyoma, Chest Pain, Liver Function Test Abnormal, Dizziness, Breast Hyperplasia, Depression, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Nausea, Breast Mass, Ovarian Cyst, Cervical Dysplasia, Amnesia, Rectocele, Visual Impairment

Drug(s) suspected as cause:
Provera
    Dosage: 10 mg, unk
    Start date: 1990-11-26

Cycrin
    Dosage: 2.5 mg, unk
    Indication: Menopause
    Start date: 1997-11-17
    End date: 1997-12-17

Prempro

Hormones
    Administration route: Topical
    Indication: Menopause
    Start date: 1991-01-01

Ogen

Provera
    Start date: 1991-01-01

Premarin
    Dosage: 0.625 mg, unk
    Indication: Menopause
    Start date: 1990-11-26
    End date: 2000-11-01

Premarin
    Administration route: Topical
    Indication: Menopause
    Start date: 1992-03-11
    End date: 1997-11-23

Estraderm
    Dosage: 0.05 mg, biw
    Start date: 1992-03-11
    End date: 1993-03-11

Premarin
    Start date: 1988-01-01
    End date: 1991-01-01

Medroxyprogesterone
    Indication: Menopause
    Start date: 1991-01-01

Provera
    Indication: Menopause
    Start date: 1988-01-01
    End date: 1991-01-01

Provera
    Dosage: 2.5 mg, unk
    End date: 2000-11-01

Climara

Estraderm
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1993-03-11

Other drugs received by patient: Methotrexate; Aspirin; Naproxen (Aleve); Magnesium Sulfate; Plavix; Macrodantin; Tamoxifen Citrate; Zantac; Prevacid; Fluconazole; Paxil; Prednisone; Folic Acid; Zoloft; Calcium Carbonate; Fosamax; Tricor

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017